Free Trial
NASDAQ:GNFT

GENFIT (GNFT) Stock Price, News & Analysis

GENFIT logo
$3.65 -0.10 (-2.67%)
As of 07/11/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About GENFIT Stock (NASDAQ:GNFT)

Key Stats

Today's Range
$3.56
$3.78
50-Day Range
$3.61
$4.62
52-Week Range
$2.55
$6.42
Volume
5,487 shs
Average Volume
10,427 shs
Market Capitalization
$182.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

GENFIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

GNFT MarketRank™: 

GENFIT scored higher than 46% of companies evaluated by MarketBeat, and ranked 575th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GENFIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GENFIT has received no research coverage in the past 90 days.

  • Read more about GENFIT's stock forecast and price target.
  • Earnings Growth

    Earnings for GENFIT are expected to decrease in the coming year, from $0.95 to ($0.57) per share.

  • Price to Book Value per Share Ratio

    GENFIT has a P/B Ratio of 2.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about GENFIT's valuation and earnings.
  • Percentage of Shares Shorted

    0.07% of the float of GENFIT has been sold short.
  • Short Interest Ratio / Days to Cover

    GENFIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GENFIT has recently decreased by 6.63%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    GENFIT does not currently pay a dividend.

  • Dividend Growth

    GENFIT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the float of GENFIT has been sold short.
  • Short Interest Ratio / Days to Cover

    GENFIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GENFIT has recently decreased by 6.63%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    GENFIT has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for GENFIT this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, GENFIT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.20% of the stock of GENFIT is held by insiders.

  • Percentage Held by Institutions

    Only 2.24% of the stock of GENFIT is held by institutions.

  • Read more about GENFIT's insider trading history.
Receive GNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GENFIT and its competitors with MarketBeat's FREE daily newsletter.

GNFT Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

GNFT Stock Analysis - Frequently Asked Questions

GENFIT's stock was trading at $3.71 at the start of the year. Since then, GNFT shares have decreased by 1.6% and is now trading at $3.65.

GENFIT (GNFT) raised $132 million in an initial public offering (IPO) on Wednesday, March 27th 2019. The company issued 5,000,000 shares at $26.33 per share. SVB Leerink and Barclays acted as the underwriters for the IPO and Bryan, Garnier, Natixis, Roth Capital Partners and H.C. Wainwright & Co. were co-managers.

Shares of GNFT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GENFIT investors own include Intercept Pharmaceuticals (ICPT), InterDigital (IDCC), NVIDIA (NVDA), Occidental Petroleum (OXY), Vaxart (VXRT), American Airlines Group (AAL) and Carnival (CCL).

Company Calendar

Today
7/12/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNFT
CIK
1757064
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$13.00
Potential Upside/Downside
+256.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
1.23
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$76.77 million
Price / Sales
2.38
Cash Flow
$0.07 per share
Price / Cash Flow
53.61
Book Value
$1.50 per share
Price / Book
2.43

Miscellaneous

Outstanding Shares
50,000,000
Free Float
47,903,000
Market Cap
$182.50 million
Optionable
Not Optionable
Beta
1.08
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:GNFT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners